Main Article Content

Abstract

The numbers of individuals with chronic conditions, particularly those with hypertension and diabetes, have a low Quality of Life as a result of their treatment and lifestyle choices. It can also cause a slew of difficulties in the body's systems, as well as unfavourable metabolic circumstances that impair one's quality of life. The goal of this study is to find out how satisfaction with hypertension affects quality of life in people with hypertension and diabetes. A six-month prospective cross-sectional study was carried out in a tertiary care facility in (District) (State). A total of 200 patients were consented to be interviewed in order to gather information on socio demographics, physical, mental, and behavioural characteristics using a standardised questionnaire. The MINICHAL scale, which has 17 questions and is divided into two domains, mental domain and somatic domain, is used to assess quality of life. It has four possible replies, with scores of 0=not at all, 1=yes, somewhat, 2=yes, a lot, and 3=yes, a lot, with a total of points ranging from 0-51. The greatest and worst levels of health are indicated by the International Diabetes Federation, while the last question is a sign of the patient's general agreement to participate in the survey. According to the findings of this study, the average quality of life in hypertension is 61.83 percent, and the average quality of life in hypertension and diabetes is 42.22 percent. Using the chi square test, a significant association was also discovered, with a p value of 0.001. This learning presentation demonstrates that self-care is important to avoid disease, and that, based on historical comments; more counselling is required in patients to improve their Quality of Life.

Keywords

Mental domain Somatic domain Chronic diseases Quality of life MINICHAL

Article Details

How to Cite
Shreya Jain, Henrita Boro, Drishti Sharma, Gurpreet Singh Multani, Sudhanshu Bansal, Saksham kumar, & Shivam Choudghal. (2021). Assessment of quality of life in diabetes and hypertensive patients attending tertiary care hospitals in (Jammu), (Jammu and Kashmir). International Journal of Research in Pharmacology & Pharmacotherapeutics, 10(3), 236-243. Retrieved from https://ijrpp.com/ijrpp/article/view/397

References

  1. [1]. Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. Plosone. 2013;8(4):62775.
  2. [2]. Saqlain M, Riaz A, Malik MN, Khan S, Ahmed A, Kamran S, et al. Medication Adherence and its Association with Health Literacy and Performance in Activities of Daily Livings among Elderly Hypertensive Patients in Islamabad, Pakistan. Medicina. 2019;55(5):163.
  3. [3]. Riaz H, Sadeeqa S, Sultana M. Hypertension-related knowledge, medication adherence and health-related quality of life among hypertensive patients in Islamabad, Pakistan. Tropical Journal of Pharmaceutical Research. 2019;18(5):1123-32.
  4. [4]. Khayyat SM, Alhazmi RS, Mohamed MM, Hadi MA. Predictors of medication adherence and blood pressure control among Saudi hypertensive patients attending primary care clinics: A cross-sectional study. PloS One. 2017;12(1):0171255.
  5. [5]. Timar R, Velea I, Timar B, Lungeanu D, Oancea C, Roman D, et al. Factors influencing the quality of life perception in patients with type 2 diabetes mellitus. Patient Preference and Adherence. 2016;10:2471.
  6. [6]. Gupta L, Khandelwal D, Lal PR, Gupta Y, Kalra S, Dutta D. Factors Determining the Success of Therapeutic Lifestyle Interventions in Diabetes–Role of Partner and Family Support. European Endocrinology. 2019;15(1):18.
  7. [7]. Singh C, Crawford K, Willey S, Hall H, Harder K, Plummer V, et al. Medication adherence among people of International Diabetes Federation an ethnicity living with chronic disease following migration to Australia. Collegian. 2020;27(2):179-84.
  8. [8]. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
  9. [9]. Poljicanin T, Ajdukovic D, Sekerija M, Pibernik-Okanovic M, Metelko Z, Mavrinac V. Diabetes mellitus and hypertension have comparable adverse effects on health-related quality of life. BMC Public Health. 2010;10(1):12.
  10. [10]. Trevisol DJ, Moreira LB, Fuchs FD, Fuchs SC. Health-related quality of life is worse in International Diabetes Federation individuals with hypertension under drug treatment: Results of population-based study. Journal of Human Hypertension. 2012;26(6):374.
  11. [11]. Erickson SR, Williams BC, Gruppen LD. Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2004;24(3):344-50.
  12. [12]. Sushma P, Gali NC, Badhela H, Palinga A, Lakshmi KR. Evaluation of medication adherence in type-2 diabetic patients in tertiary care hospital. International Journal of Research and Analytical Reviews. 2018;5(4):921-9.